Kestra Advisory Services’s DarioHealth DRIO Stock Holding History

Kestra Advisory Services’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,100	Closed	-$35.3K	–	3436
2025 Q4	$35.3K	Buy	+3,100	New	+$40.9K	﹤0.01%	4183

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Advisory Services's DRIO Position: Q1 2026 in Review

Kestra Advisory Services sold out of DarioHealth (DRIO) in Q1 2026, closing a stake of 3,100 shares — an estimated $35.3K sold.

Kestra Advisory Services first reported a position in DRIO in Q4 2025 and held it in 1 quarter. The position peaked at $35.3K in Q4 2025. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

Kestra Advisory Services reported no remaining DarioHealth position as of Q1 2026 after selling out during the quarter.
Kestra Advisory Services sold 3,100 DarioHealth shares in Q1 2026, an estimated $35.3K.
Kestra Advisory Services first reported a position in DarioHealth in Q4 2025 and held it in 1 quarter.
Kestra Advisory Services's DarioHealth position peaked at $35.3K in Q4 2025.
21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.